Kestra Advisory Services’s Sagimet Biosciences SGMT Stock Holding History
Bought
Maintained
Sold
Other funds holding SGMT
Kestra Advisory Services's SGMT Position: Q3 2026 in Review
Kestra Advisory Services held its Sagimet Biosciences (SGMT) position steady in Q3 2026 at 66,414 shares worth $656K. The position accounts for ﹤0.01% of the portfolio, ranked #2267.
Kestra Advisory Services first reported a position in SGMT in Q4 2025 and has held it in 4 quarters since. 153 funds tracked by Wall St. Rank hold SGMT as of Q3 2026.
- Kestra Advisory Services held 66,414 shares of Sagimet Biosciences worth $656K as of Q3 2026.
- Kestra Advisory Services left its Sagimet Biosciences share count unchanged in Q3 2026.
- Sagimet Biosciences made up ﹤0.01% of Kestra Advisory Services's portfolio in Q3 2026, its #2267 holding.
- Kestra Advisory Services first reported a position in Sagimet Biosciences in Q4 2025 and has held it in 4 quarters since.
- 153 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q3 2026.
Based on Kestra Advisory Services's 13F filing for Q3 2026, filed 2 Nov 2026.